INTRODUCTION
Intramural hematoma of the gastrointestinal tract is a relatively uncommon condition. It is mainly caused by blunt trauma, bleeding disorders, or anticoagulation therapy. 1 Recently, reports of intramural hematoma have increased with the use of therapeutic endoscopy for gastro-duodenal peptic ulcer bleeding. 1, 2 The risk of complications associated with endoscopic intervention is very low and mainly includes aspiration pneumonia and gut perforation. 3 Intramural duodenal hematoma is a rare complication after an endoscopic intervention, although patients susceptible to bleeding such as those with end-stage renal disease (ESRD), liver cirrhosis, or those receiving anticoagulant therapy are more susceptible. [4] [5] [6] We report a case of an intramural hematoma occurring after the endoscopic treatment of a duodenal ulcer in a patient undergoing hemodialysis (HD), followed by a secondary hematoma-induced common bile duct obstruction.
CASE REPORT
A 45-year-old man presented to emergency room of CHA Bundang Medical Center, complaining of multiple episodes of melena in 1 day. The patient had been on maintenance
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Fig. 1. Endoscopic findings. (A)
The esophago-gastro-duodenoscopy on admission revealed a deep ulcer and an exposed vessel on the base was noted at the duodenal bulb. (B) An epinephrine injection (2 mL, 1 mL) was administered to control the blood oozing from the vessel. Complete hemostasis was acquired with four hemoclippings and 2 mL of fibrin glue injection. Fig. 2 . On the 2nd hospital day, the contrast-enhanced abdominal computed tomography scan showed a huge intramural hematoma in the 2nd to 4th portions of the duodenum with compression of the common bile duct (black arrows, intramural hematoma; white arrows, common bile duct An emergency esophago-gastro-duodenoscopy (EGD) was performed due to suspected active gastrointestinal bleeding.
The endoscopy revealed a deep ulcer with exposed vessel at the duodenal bulb (Fig. 1A) . A total of 3 mL of 0.2% epinephrine injection, with subsequent hemoclipping, was administered to control the continuous oozing of blood from the exposed vessel. Moreover, 2 mL of fibrin glue injection was administered to treat the active bleeding from the duodenal ulcer (Fig. 1B) . He was conservatively treated with an intravenous proton pump inhibitor.
On the second day after the endoscopic treatment, he complained of abdominal pain, a palpable mass and jaundice. (Fig. 4) .
Total parenteral nutrition was discontinued on the 24th day
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The Korean Journal of Gastroenterology (Fig. 5) . When the amount of daily drainage was less than 5 mL and serum total bilirubin level was decreased to 4.76 mg/dL, the drainage catheter was removed. On the follow-up at 8 weeks, a repeat EGD revealed a healed duodenal ulcer with no evidence of hematoma (Fig. 6 ).
DISCUSSION
Intramural hematoma of the duodenum is a rare complication of endoscopic treatment. It is typically known to occur secondary to blunt abdominal trauma in children and young adults. 1, 2 However, this condition can occur in adults with underlying diseases that are susceptible to bleeding (e.g., liver cirrhosis, ESRD, leukemia, and any disease requiring anti-coagulation treatment), even with minimal trauma such as an endoscopic procedure. [2] [3] [4] [5] Intramural hematomas are also reported in healthy patients, without risk factors, after endoscopic biopsies. 7 In our case, the coagulation parameters and the platelet count were within the reference range. However, he had been on HD for a long time and the occurrence of hematoma in ESRD patients is well known.
In previously reported cases of intramural hematoma, most patients showed hemoperitoneum, pancreatitis, and partial or complete bowel obstruction with hematoma. Zinelis et al. 7 suggested that a significant amount of mucosal tissue can be pulled out and away from the fixed wall of the mucosa underneath, with more than 3 cm from the endoscope tip during the biopsy forceps procedure. In our case, we did not use biopsy forceps; however, we presume that the hematoma occurred due to injection during the endoscopic hemostasis.
The diagnosis of intramural duodenal hematoma is based on symptoms of bowel obstruction and a decrease in hemoglobin level without overt signs of bleeding. An enhanced abdominal CT serves as the best imaging tool for the diagnosis. In principle, the management of this condition is typically conservative treatments. Because of the rich blood supply of the duodenal wall, the hematoma is anticipated to be absorbed with time. Conservative treatments include total parenteral nutrition and electrolyte replacement, nasogastric tube decompression and careful observation.
On the other hand, surgical treatment may be considered when there is a septic condition, with obstruction secondary to the hematoma, such as the current case. In addition, aggressive treatment should be considered when there is no evidence of partial resolution after conservative treatment, or in cases of perforation or peritonitis, which increases the size of the hematoma. 7, 8 Recently, several new therapeutic strategies have been reported. Kwon et al. 6 reported a case of intramural hematoma of the duodenum, which was treated with percutaneous drainage and embolization of the bleeding focus, similar to our case. They also recommended endoscopic incision and drainage for treatment. 8 Aizawa et al.
